Tianjin Chase Sun Pharmaceutical Co.,Ltd.’s Net Profit Dropped 7.4% in 2022

Tianjin Chase Sun Pharmaceutical Co.,Ltd. (天津红日药业股份有限公司) (300026.SZ) reported a net profit of 621 million yuan in 2022, down 7.4% year-on-year.

Meanwhile, the company posted 6.7 billion yuan in revenue, down 13.3% year-on-year.

At the end of the reporting period, it had 12.6 billion yuan in total assets and 4.2 billion yuan in total liabilities, with a liability-to-asset ratio of 33%.